EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bluetongue in the Mediterranean Basin: An Overview of Recent Hotspots and Advances in Vaccine Technologies

Ikram Joubair iD, Abdellatif Errabbani iD, Soukaina Daif, Jesus Zueco, Salim Bounou, Ouafaa Fassi Fihri iD, Ismaïl Moukadiri iD

Microorganisms · 12.02.2026 · 14 (2) · 437

DOI: 10.3390/microorganisms14020437 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 12.02.2026. Verfasst von Ikram Joubair und 6 weiteren Autor:innen. Beteiligte Einrichtung: Engineering School in Biomedical & Biotechnology, Euromed Faculty of Pharmacy, Euro-Mediterranean University of Fez, Eco-Campus UEMF, Route de Meknes…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MESRSI and FOCP via ARPD, Moroccan Ministry of Higher Education, Scientific Research and Innovation, MESRSI-FOCP Research Contract.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bluetongue (BT) is a noncontagious, arthropod-borne viral disease of domestic and wild ruminants caused by bluetongue virus (BTV), an arbovirus of the Orbivirus genus within the Sedoreoviridae family. At least 36 serotypes have been identified globally; recurrent circulation of BTV-1, -4, and -8, along with the recent emergence of BTV-3 in northern Europe, underscores a persistent incursion risk for Mediterranean herds. Key drivers include climate-driven expansion of Culicoides vector niches, windborne dispersal, animal movements, and subclinical reservoirs in cattle and goats. As no specific treatment is currently available, control of bluetongue disease still relies largely on vaccination. Live-attenuated vaccines and inactivated vaccines have reduced incidence, but important limitations persist: risk of reversion and the possibility of reassortment for LAVs; requirement for multiple doses and limited cross-protection for inactivated products; and the absence of DIVA capability for both. As an alternative, next-generation platforms are under active evaluation. Subunit formulations, often VP2 combined with VP5 and/or NS1/NS2 virus-like particles (VLPs), and viral-vectored constructs demonstrate favorable safety, strong humoral and cellular responses, inherent or engineered DIVA compatibility, and potential for rapid updating against emergent serotypes. This review synthesizes recent bluetongue activity across the Mediterranean Basin and provides a critical assessment of both existing and emerging vaccine strategies, with a focus on recommending next-generation platforms that emphasize DIVA-compliant, multiserotype, and adaptable vaccination approaches, supported by integrated surveillance and vector control in the region.

Schlagwörter

Stichwörter der Autor:innen

DIVAMediterranean basinbluetongue virus (BTV)epidemiologynext generation vaccineserotypesvaccinationvirus outbreaks

Autor:innen und Institutionen

  • Engineering School in Biomedical & Biotechnology, Euromed Faculty of Pharmacy, Euro-Mediterranean University of Fez, Eco-Campus UEMF, Route de Meknes (RN6, Rond-Point Bensouda), Fez 30070, Morocco.
  • Unidad de Microbiología, Facultad de Farmacia, Universidad de Valencia, Avda. Vicente Andrés Estelles s/n, Burjassot, 46100 Valencia, Spain.
  • MPCAE Laboratory-Materials, Natural Substances, Environment and Modeling Team (MSNEM), Polydisciplinary Faculty of Taza (FPT), Sidi Mohamed Ben Abdellah University (USMBA) of Fez, Taza BP 1223, Morocco.
  • Pathology and Veterinary Public Health Department, Institut Agronomique et Vétérinaire HASSAN II, P.O. Box 6202, Rabat 10000, Morocco.

ORCID-Profile: Ikram Joubair, Abdellatif Errabbani, Ouafaa Fassi Fihri, Ismaïl Moukadiri

Förderung

  • MESRSI and FOCP via ARPD
  • Moroccan Ministry of Higher Education, Scientific Research and Innovation
  • MESRSI-FOCP Research Contract
  • Euromed University of Fes

Zitieren

APA

Joubair, I., Errabbani, A., Daif, S., Zueco, J., Bounou, S., Fassi Fihri, O., & Moukadiri, I. (2026). Bluetongue in the Mediterranean Basin: An Overview of Recent Hotspots and Advances in Vaccine Technologies. Microorganisms, 14(2), 437. https://doi.org/10.3390/microorganisms14020437

Vancouver

Joubair I, Errabbani A, Daif S, Zueco J, Bounou S, Fassi Fihri O, et al. Bluetongue in the Mediterranean Basin: An Overview of Recent Hotspots and Advances in Vaccine Technologies. Microorganisms. 2026;14(2):437. doi:10.3390/microorganisms14020437

BibTeX
@article{Joubair2026,
  author = {Joubair, Ikram and Errabbani, Abdellatif and Daif, Soukaina and Zueco, Jesus and Bounou, Salim and Fassi Fihri, Ouafaa and Moukadiri, Ismaïl},
  title = {Bluetongue in the Mediterranean Basin: An Overview of Recent Hotspots and Advances in Vaccine Technologies},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {437},
  doi = {10.3390/microorganisms14020437}
}
Kostenlos starten →